Summary In this study cell lines have been used to determine the level of correlation between three assays which are in use for in vitro prediction of human tumour chemosensitivity. The methods which were compared included a clonogenic assay, a monolayer assay and a short-term biochemical assay. The results indicated that the monolayer and clonogenic assays were either directly comparable or could be made comparable by reducing the drug exposure time in the monolayer assay. The biochemical assay also gave comparable results for 3 of the 5 drugs tested. It was concluded that although the 3 assays did not produce identical dose-response curves, the assays were equally valid when used for predictive testing because selection of cut-off points which were based on retrospective correlations between in vitro sensitivity data and response data, as established by other authors, compensated for differences in sensitivity between the assays.
Interest in the use of in vitro predictive tests for the determination of chemosensitivity of human tumours has escalated in recent years and from 1970 there have been numerous publications in which different methodologies have been described. The methods can be simply categorised into (i) assays using short-term cultures of cell suspensions (e.g. Volm et al., 1979 ; Group for Sensitivity Testing (KSST), 1981; Sanfilippo et al., 1981) (ii) assays using cell monolayers (e.g. Mitchell et al., 1972; Holmes & Little, 1974; Berry et al., 1975; Shrivastav et al., 1980; Kornblith et al., 1981; Wilson & Neal, 1981) (iii) assays which measure clonogenic cell survival (e.g. Hamburger et Salmon et al., 1978; Rosenblum et al., 1978; Sarosdy et al., 1982) . Irrespective of the type of assay used, good correlation between in vitro results and response of individual patients has been reported by the majority of groups, particularly in the accurate prediction of clinical resistance (e.g. Wheeler et al., 1974 ; Group for Sensitivity Testing (KSST) 1981; Salmon et al., 1978) .
Advantages and disadvantages are associated with each assay, and the variety of methods used indicates the dilemma of those in the field of in vitro predictive testing, as to which assay is the most relevant. different methodologies were compared using T, lymphoma cells, the only reliable dose-dependent index of drug effect was found to be colony formation (Roper & Drewinko, 1976) . No recent studies have been carried out in which different methodologies which are presently in use for chemosensitivity testing of human tumours have been evaluated for comparability of assays in terms of their ability to predict the same chemosensitivity pattern for the same tumour. We have therefore chosen to compare three assays which are in current use: these are a short-term biochemical assay (B) used extensively in W. Germany (Volm et al., 1974; KSST, 1981) , a monolayer assay using microtitration plates (M) (Freshney et al., 1975; Wilson & Neal, 1981) and a clonogenic assay (C), which is basically as described by Hamburger (Hamburger et al., 1978) . Assay characteristics are compared in Table I . Preliminary results are presented using cell lines which have provided us with a continuous source of material for replicate studies and have also eliminated complications introduced by the presence of normal cells.
Materials and methods

Cell lines
The cell lines used in these studies were T13-adeno 2 transformed rat embryo fibroblasts (Harwood, 1975) and MCF-7-human breast adenocarcinoma cells (Soule et al., 1973 International, PLC). After incubation cells were immediately treated with ice cold 5% trichloroacetic acid followed by methanol, and the amount of radioactivity incorporated into the acid insoluble residue was determined using liquid Monolayer assay (M) Drug solutions were added 24 h after tumour cells had been plated at 2 x 104 viable cells/well into 96-well flat-bottomed microtitration plates (Nunc), and incubations were carried out at 37°C in an atmosphere of 95% air/5% CO2. In the routine procedure cells were exposed to drugs for 48h, washed with PBS and allowed a 24 h recovery period in fresh growth medium (=M48). Because there were differences in exposure time between the 3 routine assays, a reduced exposure time was also used in the monolayer assay to determine the effect of this variable on assay comparability. Thus in some assays cells were exposed to drugs for 3h, washed in PBS and allowed a 69 h recovery period in growth medium (= M3 were routinely obtained. Higher values did sometimes occur, the incidence being the greatest in the latter two assays. Results were generally obtained for at least 2 experiments for each drug and assay.
Classification of chemosensitivity of cell lines The ultimate objective of any predictive test is the classification of a tumour cell population as sensitive or resistant to a particular drug. The 3 assays in this study have all been used to investigate human tumour material and cut-off points have been defined for each assay by the original groups, which were based on correlations between in vitro results and clinical response data. These same cut-off points have therefore been selected for sensitivity classification of the cell lines since their validity has been described elsewhere. For B, a cut-off point of <65% of control at 2 jugml-1 of ADM was used to define the cell lines as sensitive (cf. KSST, 1981) . Cut-off points for the other drugs have not been defined and therefore for the purpose of this study 65% has been arbitrarily selected for CYT, FU, BLM and CIS. For M a cut-off point of < 50% of control was used to define sensitivity at 1 and 10 gml-P (Wilson & Neal, 1981) . For C, areas under the curve were originally used to define sensitivity (Salmon et al., 1978) but other groups using the same method have used <30% of control (Ozolls et al., 1980) , and for comparison between assays the latter has been chosen, again at 1 and 10 igml-1. When results of duplicate experiments differed, the cell line was classed as border-line sensitivity (R/S).
Results
Under the conditions used, plating efficiencies of 0.8-1% were obtained for both cell lines, giving 400-500 colonies per control plate. The doubling times in monolayer for each cell line were also similar at -24 h. The results of duplicate experiments obtained with both cell lines for all drugs and assays are shown in Figures 1-3 and Table II .
Adriamycin
Results obtained with ADM are shown in Figure 1 and Table II . The 3 assays predicted sensitivity to ADM at 2pgml-' for both cell lines, and were therefore directly comparable. Reduction of the drug exposure time in M to 3 h (M3) did not affect the sensitivity classification and the different assays therefore correlated despite the differences in exposure time.
Cis platinum Results obtained with CIS are shown in Figure 2 and Table II . At 1 pg ml-1 all assays predicted resistance for both cell lines, with the exception of B, which predicted borderline sensitivity of Tl 3 cells (R/S). At lOpgml-', M48, M3 and C assays correlated in predicting sensitivity of T13 cells whilst B again predicted borderline sensitivity. Although C showed extreme sensitivity of T13 at 10ygml-1, M3 showed only borderline sensitivity.
Thus M48 and C showed better correlation despite the differences in exposure time. At 0 Mgml-' M48 and C both predicted border-line sensitivity of MCF 7 and B predicted resistance. All 3 assays therefore demonstrated a greater resistance of MCF 7 cells to CIS.
5-fluorouracil, Bleomycin, cytosine arabinoside Results for FU, BLM, and CYT are shown in Figure 3 and Table II which were attributable to the differences in exposure time. The routine monolayer assay predicted sensitivity to FU at 1 and 10pgml-P whilst C predicted resistance at 1 gml-' and borderline sensitivity at 10 yg ml -. In M3 resistance was also predicted at lygml-' but the cells were still sensitive at 10ygml-'. Reduction of exposure times to comparable levels between assays did therefore contribute towards eliminating differences between C and M. The biochemical assay indicated resistance to FU at both concentration levels. When BLM was tested B actually predicted sensitivity at the lowest concentration tested, but at the two higher concentrations the cell line was resistant according to the sensitivity classification for this assay. In M48 and M3 cells were sensitive at 1 and 10pgml-1 with comparable dose-response curves despite the differences in exposure time, whilst in C cells were resistant to l gml-1, but sensitive to 10pgml-'.
Thus, as for FU, C and M were comparable at lOpgml-'. With CYT C predicted borderline sensitivity at lOpgml-', which correlated with M3. M48 did not correlate with C since it predicted sensitivity both at 1 and 10pgml-P. It did, however, correlate with B which also predicted sensitivity at 1 and l10gml-.
Discussion
In this investigation the degree of comparability between three assays routinely used for predicting the chemosensitivity of human tumours was found to be dependent on the drug and duration of drug exposure when cell lines were used. With all drugs tested the monolayer and clonogenic assays were either comparable despite the differences in drug exposure time or could be made comparable by reducing the exposure time in monolayer assay. This indicates that the total proliferating cell population, the chemosensitivity of which is determined in M, shares the same chemosensitivity profile as that of the clonogenic population. It is therefore feasible to suggest that the monolayer assay shares the biological validity of the clonogenic assay. The inability of normal cells to proliferate in soft agar is a factor which has particularly recommended the clonogenic assay for chemosensitivity testing of human tumours, because for many tumours stromal cell overgrowth precludes the use of a monolayer assay. However, the relevance of the clonogenic assay in in vitro predictive testing has been questioned because several groups have failed to repeat the original findings (Rupniak & Hill, 1980; Bertoncello et al., 1982; Agrez et al., 1982) and the very jow plating 61 efficiencies which have been obtained with human tumours reduces the success rate in obtaining chemosensitivity results. The results reported here lead to the conclusion that, at least for tumours in which a pure population of tumour cells can be obtained the validity of the monolayer assay equates with that of the clonogenic assay. A recent publication reports good correlation between chemosensitivity results obtained using a monolayer cloning assay and the monolayer/microtitration plate assay with human astrocytomas (Morgan et al., 1983) and therefore indicates that the findings of the present study may also be relevant for primary human tumours.
Although the biochemical assay was less sensitive than the other two assays, the higher cut-off point compensated for this and the assay was able to predict sensitivity to ADM which confirms the original findings (KSST, 1981) , and also to CYT, CIS and possibly BLM. More recent results have shown that the low levels of inhibition which are common to this assay are a result of technical artefacts which can be eliminated by changing the methodology (Wilson et al., 1983) and it is possible therefore that this assay could be equally valid for predictive testing.
Considering the differences in methodologies between the assays, it is hardly surprising that the dose-response curves were not comparable for some of the drugs. The results do indicate however, that differences between the assays are automatically compensated for when cut-off points which are based on retrospective correlations between results obtained with the particular assay using human tumour material and clinical response data are used to define sensitivity. Although this study has not used primary tumour material it is valid to extrapolate the findings to this situation since the assays have all been proved in a clinical context. In conclusion therefore, provided the assay produces a dose-related depression of the chosen end-point the methodology is irrelevant if retrospective correlations between in vitro data and response data are made for a number of specimens, in order to define sensitivity.
